Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - A European Perspective

Adriano Alatri, Anna-Elina Armstrong, Andreas Greinacher, Andreas Koster, Sibylle A. Kozek-Langenecker, Marcus D. Lance, Andreas Link, Jorn D. Nielsen, Per Morten Sandset, Alexander J. Spanjersberg, Michael Spannagl

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)426-433
JournalThrombosis Research
Volume129
Issue number4
DOIs
Publication statusPublished - Apr 2012

Keywords

  • argatroban
  • heparin-induced thrombocytopenia
  • anticoagulation
  • intensive care unit patients

Cite this

Alatri, A., Armstrong, A-E., Greinacher, A., Koster, A., Kozek-Langenecker, S. A., Lance, M. D., Link, A., Nielsen, J. D., Sandset, P. M., Spanjersberg, A. J., & Spannagl, M. (2012). Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - A European Perspective. Thrombosis Research, 129(4), 426-433. https://doi.org/10.1016/j.thromres.2011.11.041